 |
|
|
| |
Long-term Tenofovir Disoproxil Fumarate (TDF) Therapy and the Risk of Hepatocellular Carcinoma
|
| |
| |
Reported by Jules Levin
EASL 2013 April 24-28 Amsterdam
W. Ray Kim1, Thomas Berg2, Rohit Loomba3, Raul Aguilar Schall4, Phillip Dinh4, Leland J. Yee4, Eduardo Bruno Martins4,
John F. Flaherty4, Selim Gurel5, Maria Buti6, Patrick Marcellin7
1Mayo Clinic, Rochester, MN, USA; 2Universitätsklinikum Leipzig, Germany; 3University of California at San Diego, USA; 4Gilead Sciences, Inc., Foster City, CA; 5University of Uludag, Bursa, Turkey; 6Hospital General Universitari Vall d'Hebron, Barcelona, Spain; 7Hôpital Beaujon, University of Paris, Clichy, France
|
| |
|
|
|
|
|
